Country for PR: United States
Contributor: PR Newswire New York
Wednesday, November 10 2021 - 00:33
Ceres Nanosciences Establishes Nine Wastewater-based COVID-19 Surveillance Centers of Excellence Under NIH RADx Initiative
MANASSAS, Va., Nov. 10, 2021 /PRNewswire-AsiaNet/ --

Ceres Nanosciences (Ceres), a privately held company that makes innovative 
products to improve life science research and diagnostic testing, is announcing 
the establishment of nine wastewater-based epidemiology centers of excellence, 
as part of the April 2021 ( 
) $8.2 million award from the National Institutes of Health (NIH) Rapid 
Acceleration of Diagnostics (RADx(SM)) initiative.
Logo -

Wastewater-based epidemiology can help communities monitor infection dynamics 
for SARS-CoV-2 and can serve as an early-warning system for the virus in a 
population, but widespread implementation has been stymied by lack of robust, 
high-throughput viral concentration methods. 

Ceres' Nanotrap(R) Magnetic Virus Particles address this problem by enabling 
rapid viral concentration directly from raw sewage, significantly reducing the 
time and effort required to process samples. Wastewater testing methods powered 
by Nanotrap(R) Particles enable wastewater-based epidemiology at multiple 
levels in a community, including at the building level, at the neighborhood 
sewershed level, and at the wastewater treatment plant level. 

"Our customers have processed tens of thousands of samples from college dorms, 
K-12 schools, sleepaway camps, government facilities, and wastewater treatment 
plants," said Ben Lepene, Chief Technology Officer at Ceres Nanosciences. "A 
recent study by one of our university customers showed that 85% of the 
individual COVID-19 cases ( 
) on campus were preceded by positive wastewater results." 

Each Center of Excellence was selected ( 
) based on its ability to utilize the expanded capacity to extend services into 
underserved and underprivileged communities and to provide critical information 
to public health decision makers. Each site received the materials and on-site 
training from Ceres' field applications team to implement an automated 
protocol, which increases capacity to 100 samples per day and improves 
turnaround times to less than eight hours.

"These sites encompass non-profit, university, public health, and commercial 
testing labs in eight states with a total population of more than 120 million 
people," said Tara Jones-Roe, Vice President of Sales and Marketing for Ceres 
Nanosciences. "We are very proud of this amazing set of organizations and look 
forward to identifying additional sites."

The sites announced today are Arizona State University with OneWaterOneHealth, 
CIAN Diagnostics, Public Health Laboratory of East Texas, University at 
Buffalo, UCLA, UC Davis with UC Merced, University of Connecticut, University 
of Kansas, and West Virginia University. 

Full details are available at 

Press Contact:
Ross M. Dunlap
Ceres Nanosciences, Inc
1.800.615.0418 ext. 202

SOURCE Ceres Nanosciences, Inc